JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB263212

Human GANC knockout HeLa cell lysate

Be the first to review this product! Submit a review

|

(0 Publication)

GANC KO cell lysate available now. KO validated by. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, 4 bp deletion in exon11.

View Alternative Names

GANC_HUMAN, Glucosidase alpha neutral C, MGC138256, Neutral alpha-glucosidase C

1 Images
Sanger Sequencing - Human GANC knockout HeLa cell lysate (AB263212)
  • Sanger seq

Unknown

Sanger Sequencing - Human GANC knockout HeLa cell lysate (AB263212)

Homozygous : 4 bp deletion in exon11

Key facts

Cell type

HeLa

Species or organism

Human

Tissue

Cervix

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, 4 bp deletion in exon11.

Disease

Adenocarcinoma

Product details

Knockout cell lysate achieved by CRISPR/Cas9.

REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.

User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.

This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1Kit": { "sellingSize": "1 Kit", "publicAssetCode":"ab263212-1Kit", "assetComponentDetails": [ { "size":"1 x 100 µg", "name":"Human GANC knockout HeLa cell lysate", "number":"AB263212-CMP02", "productcode":"" }, { "size":"1 x 100 µg", "name":"Human wild-type HeLa cell lysate", "number":"AB263212-CMP01", "productcode":"" } ] } } }

Properties and storage information

Gene name
GANC
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

The GANC gene encodes the enzyme Glucosidase Alpha Neutral C (GAN Glucosidase) also commonly known as neutral alpha-glucosidase C. It plays an important role in carbohydrate metabolism by hydrolyzing terminal non-reducing (14)-linked alpha-glucose residues to release alpha-glucose. The enzyme mass is approximately 106 kDa. GANC is widely expressed in human tissues with significant presence in the liver pancreas and intestine where it contributes to glucose homeostasis and nutrient absorption.
Biological function summary

This enzyme is important for carbohydrate digestion and glucose production. GANC is not known to form part of a larger protein complex but acts individually to catalyze the breakdown of polysaccharides and oligosaccharides. By converting these molecules into glucose it provides an immediate source of energy for cells thereby supporting cellular metabolism and overall organismal energy balance.

Pathways

The enzyme takes part in the carbohydrate metabolism pathway and the glycogen degradation pathway. These pathways are instrumental in energy production and storage management in cells. GANC works in conjunction with enzymes like glycogen phosphorylase and beta-amylase to regulate the conversion of stored glycogen into glucose ensuring proper energy supply during fasting and physical activity.

GANC associations include diabetes mellitus and glycogen storage disorders. Dysfunction or imbalance in GANC activity can lead to improper glucose regulation characteristic in diabetes where glucose metabolism is impaired. The enzyme collaborates with insulin and glucagon regulation mechanisms to maintain glucose homeostasis. In glycogen storage disorders improper degradation of glycogen can exacerbate energy supply issues highlighting the significance of GANC in maintaining normal glucose levels and metabolic functions.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com